1361021-39-7

Basic information

• Product Name: 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene
• Synonyms: 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene
• CAS NO: 1361021-39-7
• Molecular Formula: C7H5BrINO3
• Molecular Weight: 357.92797
• Mol File: 1361021-39-7.mol

Chemical Properties

• Boiling Point: 381.9±42.0 °C(Predicted)
• Appearance: /
• Density: 2.188±0.06 g/cm3(Predicted)
• CAS DataBase Reference: 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene(1361021-39-7)
• EPA Substance Registry System: 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene(1361021-39-7)

Safety Data

• Hazardous Substances Data: 1361021-39-7(Hazardous Substances Data)

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule of the compound.

Explanation

1-Bromo-4-iodo-2-methoxy-5-nitro-benzene is derived from benzene, a basic aromatic hydrocarbon, by attaching various functional groups to its structure.

Explanation

These are the specific functional groups attached to the benzene ring, which give the compound its unique chemical properties and reactivity.

Explanation

The compound is used as a building block in the synthesis of various organic compounds, including pharmaceuticals and agrochemicals.

Explanation

Due to its multiple functional groups, 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene can be used in a wide range of chemical reactions and applications.

Explanation

The compound is known for its high reactivity, which allows it to participate in various chemical reactions, such as nucleophilic substitution and metal-catalyzed cross-coupling reactions.

Explanation

The compound has potential applications in the development of new materials and polymers, thanks to its unique structure and reactivity.

Explanation

These are two common types of chemical reactions that 1-Bromo-4-iodo-2-methoxy-5-nitro-benzene can undergo, which contribute to its utility in organic synthesis and material science.

Derivative of benzene

Yes

Functional groups

Bromine, Iodine, Methoxy, and Nitro

Use in organic synthesis

Yes

Versatility

High

Reactivity

High

Applications in material science

Yes

Chemical reactions

Nucleophilic substitution and metal-catalyzed cross-coupling

Upstream product

• 16133-49-6 5-methoxy-2-nitroaniline 
• 1635-61-6 5-chloro-2-nitroaniline 
• 173312-36-2 4-bromo-5-methoxy-2-nitrobenzeneamine 

Relevant articles and documents

COMBINATION THERAPY

The invention provides a combinations and pharmaceutical compositions comprising (i) a compound which is an indane according to Formula (I) or a pharmaceutically acceptable salt thereof; and (ii) one or more CFTR modulator; wherein R1, R2

INDANE DERIVATIVES FOR USE IN THE TREATMENT OF BACTERIAL INFECTION

The invention relates to a compound which is an indane according to Formula (I), or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, n and p are as defined herein

METHODS AND COMPOSITIONS FOR MODULATING SPLICING

Described herein are small molecule splicing modulator compounds that modulate splicing of mRNA, such as pre-mRNA, encoded by genes, and methods of use of the small molecule splicing modulator compounds for modulating splicing and treating diseases and conditions.

CHEMICAL COMPOUNDS AS ANTIBIOTICS

The invention relates to a compound which is an indane derivative according to Formula (I), or a pharmaceutically acceptable salt thereof, [FORMULA (I)] wherein R1, R2, R3, n, R4, p? q, L, ?, X and m are as defined herein. The compounds are useful in the treatment of antibacterial infection either as stand alone antibiotics, or in combination with further antibiotics. The compounds can also be used in vitro, for example in cleaning compositions.

Conformationally restricted dynamic supramolecular catalysts for substrate-selective epoxidations

A second generation of a substrate-selective dynamic supramolecular catalytic system consisting of a catalyst part and a receptor part, connected by a hydrogen-bonding motif, has been realized based on rational design. The results from analyses of the equilibrium mixture of the species generated by the components of the first generation system led us to selectively lock the cisoid conformation of the catalyst part to increase the amount of the substrate-selective catalytic cavity in the equilibrium mixture. This was realized by strapping the catalyst part by organic synthesis. This strapping led to an increase in substrate selectivity in the pair-wise competitive epoxidations of pyridyl- vs. phenyl-appended styrenes and pyridyl- vs. phenyl-appended stilbenes of both Z- and E- configuration compared to the first generation system, reaching 3.4:1 as the highest substrate selectivity for Z-mono-pyridyl-stilbene (27a) vs. the corresponding all-carbon analogue (28a) and for E-dipyridyl-stilbene (26b) vs. the corresponding all-carbon analogue (28b), respectively.

Stereocontrolled total synthesis of (-)-eudistomin C

A stereocontrolled total synthesis of (-)-eudistomin C was accomplished in 18-step sequence with an overall yield of 7.7%. The synthesis features the diastereoselective Pictet-Spengler reaction of a tryptamine derivative and the Garner aldehyde catalyzed